Clinical Trial Update: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating decitabine in iodine-refractory metastatic papillary or follicular thyroid cancer completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Thyroid Cancer
• Papillary Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-09-01